CORCEPT THERAPEUTICS INC — Director's Dealing 2017

Dec 12, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2017-09-05

Reporting Person: Robb Gary Charles (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-05	Common Stock	G	820	$0.00	Acquired	820	Indirect
2017-09-05	Common Stock	G	820	$0.00	Acquired	820	Indirect
2017-09-05	Common Stock	G	820	$0.00	Acquired	820	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6858	Direct

Footnotes

F1: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.